Global Castration-resistant Prostate Cancer Drugs Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Castration-resistant Prostate Cancer Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Castration-resistant Prostate Cancer Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Castration-resistant Prostate Cancer Drugs market in any manner.
Global Castration-resistant Prostate Cancer Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Astellas
Janssen
AstraZeneca
Bayer
Hengrui
CTTQ
Sanofi
Hansoh
Clovis Oncology
Zhendong Pharmaceutical
Merck
Market Segmentation (by Type)
Oral
Intravenous Injection
Others
Market Segmentation (by Application)
Hospital
Specialty Clinic
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Castration-resistant Prostate Cancer Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Castration-resistant Prostate Cancer Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Castration-resistant Prostate Cancer Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Castration-resistant Prostate Cancer Drugs market in any manner.
Global Castration-resistant Prostate Cancer Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Astellas
Janssen
AstraZeneca
Bayer
Hengrui
CTTQ
Sanofi
Hansoh
Clovis Oncology
Zhendong Pharmaceutical
Merck
Market Segmentation (by Type)
Oral
Intravenous Injection
Others
Market Segmentation (by Application)
Hospital
Specialty Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Castration-resistant Prostate Cancer Drugs Market
- Overview of the regional outlook of the Castration-resistant Prostate Cancer Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Castration-resistant Prostate Cancer Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Castration-resistant Prostate Cancer Drugs
1.2 Key Market Segments
1.2.1 Castration-resistant Prostate Cancer Drugs Segment by Type
1.2.2 Castration-resistant Prostate Cancer Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Castration-resistant Prostate Cancer Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Castration-resistant Prostate Cancer Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Castration-resistant Prostate Cancer Drugs Sales by Manufacturers (2019-2024)
3.2 Global Castration-resistant Prostate Cancer Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Castration-resistant Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Castration-resistant Prostate Cancer Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Castration-resistant Prostate Cancer Drugs Sales Sites, Area Served, Product Type
3.6 Castration-resistant Prostate Cancer Drugs Market Competitive Situation and Trends
3.6.1 Castration-resistant Prostate Cancer Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Castration-resistant Prostate Cancer Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CASTRATION-RESISTANT PROSTATE CANCER DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Castration-resistant Prostate Cancer Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Type (2019-2024)
6.3 Global Castration-resistant Prostate Cancer Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Castration-resistant Prostate Cancer Drugs Price by Type (2019-2024)
7 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Castration-resistant Prostate Cancer Drugs Market Sales by Application (2019-2024)
7.3 Global Castration-resistant Prostate Cancer Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Castration-resistant Prostate Cancer Drugs Sales Growth Rate by Application (2019-2024)
8 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Castration-resistant Prostate Cancer Drugs Sales by Region
8.1.1 Global Castration-resistant Prostate Cancer Drugs Sales by Region
8.1.2 Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Castration-resistant Prostate Cancer Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Castration-resistant Prostate Cancer Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Castration-resistant Prostate Cancer Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Castration-resistant Prostate Cancer Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Castration-resistant Prostate Cancer Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Castration-resistant Prostate Cancer Drugs Basic Information
9.1.2 Pfizer Castration-resistant Prostate Cancer Drugs Product Overview
9.1.3 Pfizer Castration-resistant Prostate Cancer Drugs Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Castration-resistant Prostate Cancer Drugs SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Astellas
9.2.1 Astellas Castration-resistant Prostate Cancer Drugs Basic Information
9.2.2 Astellas Castration-resistant Prostate Cancer Drugs Product Overview
9.2.3 Astellas Castration-resistant Prostate Cancer Drugs Product Market Performance
9.2.4 Astellas Business Overview
9.2.5 Astellas Castration-resistant Prostate Cancer Drugs SWOT Analysis
9.2.6 Astellas Recent Developments
9.3 Janssen
9.3.1 Janssen Castration-resistant Prostate Cancer Drugs Basic Information
9.3.2 Janssen Castration-resistant Prostate Cancer Drugs Product Overview
9.3.3 Janssen Castration-resistant Prostate Cancer Drugs Product Market Performance
9.3.4 Janssen Castration-resistant Prostate Cancer Drugs SWOT Analysis
9.3.5 Janssen Business Overview
9.3.6 Janssen Recent Developments
9.4 AstraZeneca
9.4.1 AstraZeneca Castration-resistant Prostate Cancer Drugs Basic Information
9.4.2 AstraZeneca Castration-resistant Prostate Cancer Drugs Product Overview
9.4.3 AstraZeneca Castration-resistant Prostate Cancer Drugs Product Market Performance
9.4.4 AstraZeneca Business Overview
9.4.5 AstraZeneca Recent Developments
9.5 Bayer
9.5.1 Bayer Castration-resistant Prostate Cancer Drugs Basic Information
9.5.2 Bayer Castration-resistant Prostate Cancer Drugs Product Overview
9.5.3 Bayer Castration-resistant Prostate Cancer Drugs Product Market Performance
9.5.4 Bayer Business Overview
9.5.5 Bayer Recent Developments
9.6 Hengrui
9.6.1 Hengrui Castration-resistant Prostate Cancer Drugs Basic Information
9.6.2 Hengrui Castration-resistant Prostate Cancer Drugs Product Overview
9.6.3 Hengrui Castration-resistant Prostate Cancer Drugs Product Market Performance
9.6.4 Hengrui Business Overview
9.6.5 Hengrui Recent Developments
9.7 CTTQ
9.7.1 CTTQ Castration-resistant Prostate Cancer Drugs Basic Information
9.7.2 CTTQ Castration-resistant Prostate Cancer Drugs Product Overview
9.7.3 CTTQ Castration-resistant Prostate Cancer Drugs Product Market Performance
9.7.4 CTTQ Business Overview
9.7.5 CTTQ Recent Developments
9.8 Sanofi
9.8.1 Sanofi Castration-resistant Prostate Cancer Drugs Basic Information
9.8.2 Sanofi Castration-resistant Prostate Cancer Drugs Product Overview
9.8.3 Sanofi Castration-resistant Prostate Cancer Drugs Product Market Performance
9.8.4 Sanofi Business Overview
9.8.5 Sanofi Recent Developments
9.9 Hansoh
9.9.1 Hansoh Castration-resistant Prostate Cancer Drugs Basic Information
9.9.2 Hansoh Castration-resistant Prostate Cancer Drugs Product Overview
9.9.3 Hansoh Castration-resistant Prostate Cancer Drugs Product Market Performance
9.9.4 Hansoh Business Overview
9.9.5 Hansoh Recent Developments
9.10 Clovis Oncology
9.10.1 Clovis Oncology Castration-resistant Prostate Cancer Drugs Basic Information
9.10.2 Clovis Oncology Castration-resistant Prostate Cancer Drugs Product Overview
9.10.3 Clovis Oncology Castration-resistant Prostate Cancer Drugs Product Market Performance
9.10.4 Clovis Oncology Business Overview
9.10.5 Clovis Oncology Recent Developments
9.11 Zhendong Pharmaceutical
9.11.1 Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Basic Information
9.11.2 Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Product Overview
9.11.3 Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Product Market Performance
9.11.4 Zhendong Pharmaceutical Business Overview
9.11.5 Zhendong Pharmaceutical Recent Developments
9.12 Merck
9.12.1 Merck Castration-resistant Prostate Cancer Drugs Basic Information
9.12.2 Merck Castration-resistant Prostate Cancer Drugs Product Overview
9.12.3 Merck Castration-resistant Prostate Cancer Drugs Product Market Performance
9.12.4 Merck Business Overview
9.12.5 Merck Recent Developments
10 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET FORECAST BY REGION
10.1 Global Castration-resistant Prostate Cancer Drugs Market Size Forecast
10.2 Global Castration-resistant Prostate Cancer Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Castration-resistant Prostate Cancer Drugs Market Size Forecast by Region
10.2.4 South America Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Castration-resistant Prostate Cancer Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Castration-resistant Prostate Cancer Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Castration-resistant Prostate Cancer Drugs by Type (2025-2030)
11.1.2 Global Castration-resistant Prostate Cancer Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Castration-resistant Prostate Cancer Drugs by Type (2025-2030)
11.2 Global Castration-resistant Prostate Cancer Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Castration-resistant Prostate Cancer Drugs Sales (K Units) Forecast by Application
11.2.2 Global Castration-resistant Prostate Cancer Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Castration-resistant Prostate Cancer Drugs
1.2 Key Market Segments
1.2.1 Castration-resistant Prostate Cancer Drugs Segment by Type
1.2.2 Castration-resistant Prostate Cancer Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Castration-resistant Prostate Cancer Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Castration-resistant Prostate Cancer Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Castration-resistant Prostate Cancer Drugs Sales by Manufacturers (2019-2024)
3.2 Global Castration-resistant Prostate Cancer Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Castration-resistant Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Castration-resistant Prostate Cancer Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Castration-resistant Prostate Cancer Drugs Sales Sites, Area Served, Product Type
3.6 Castration-resistant Prostate Cancer Drugs Market Competitive Situation and Trends
3.6.1 Castration-resistant Prostate Cancer Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Castration-resistant Prostate Cancer Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CASTRATION-RESISTANT PROSTATE CANCER DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Castration-resistant Prostate Cancer Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Type (2019-2024)
6.3 Global Castration-resistant Prostate Cancer Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Castration-resistant Prostate Cancer Drugs Price by Type (2019-2024)
7 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Castration-resistant Prostate Cancer Drugs Market Sales by Application (2019-2024)
7.3 Global Castration-resistant Prostate Cancer Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Castration-resistant Prostate Cancer Drugs Sales Growth Rate by Application (2019-2024)
8 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Castration-resistant Prostate Cancer Drugs Sales by Region
8.1.1 Global Castration-resistant Prostate Cancer Drugs Sales by Region
8.1.2 Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Castration-resistant Prostate Cancer Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Castration-resistant Prostate Cancer Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Castration-resistant Prostate Cancer Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Castration-resistant Prostate Cancer Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Castration-resistant Prostate Cancer Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Castration-resistant Prostate Cancer Drugs Basic Information
9.1.2 Pfizer Castration-resistant Prostate Cancer Drugs Product Overview
9.1.3 Pfizer Castration-resistant Prostate Cancer Drugs Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Castration-resistant Prostate Cancer Drugs SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Astellas
9.2.1 Astellas Castration-resistant Prostate Cancer Drugs Basic Information
9.2.2 Astellas Castration-resistant Prostate Cancer Drugs Product Overview
9.2.3 Astellas Castration-resistant Prostate Cancer Drugs Product Market Performance
9.2.4 Astellas Business Overview
9.2.5 Astellas Castration-resistant Prostate Cancer Drugs SWOT Analysis
9.2.6 Astellas Recent Developments
9.3 Janssen
9.3.1 Janssen Castration-resistant Prostate Cancer Drugs Basic Information
9.3.2 Janssen Castration-resistant Prostate Cancer Drugs Product Overview
9.3.3 Janssen Castration-resistant Prostate Cancer Drugs Product Market Performance
9.3.4 Janssen Castration-resistant Prostate Cancer Drugs SWOT Analysis
9.3.5 Janssen Business Overview
9.3.6 Janssen Recent Developments
9.4 AstraZeneca
9.4.1 AstraZeneca Castration-resistant Prostate Cancer Drugs Basic Information
9.4.2 AstraZeneca Castration-resistant Prostate Cancer Drugs Product Overview
9.4.3 AstraZeneca Castration-resistant Prostate Cancer Drugs Product Market Performance
9.4.4 AstraZeneca Business Overview
9.4.5 AstraZeneca Recent Developments
9.5 Bayer
9.5.1 Bayer Castration-resistant Prostate Cancer Drugs Basic Information
9.5.2 Bayer Castration-resistant Prostate Cancer Drugs Product Overview
9.5.3 Bayer Castration-resistant Prostate Cancer Drugs Product Market Performance
9.5.4 Bayer Business Overview
9.5.5 Bayer Recent Developments
9.6 Hengrui
9.6.1 Hengrui Castration-resistant Prostate Cancer Drugs Basic Information
9.6.2 Hengrui Castration-resistant Prostate Cancer Drugs Product Overview
9.6.3 Hengrui Castration-resistant Prostate Cancer Drugs Product Market Performance
9.6.4 Hengrui Business Overview
9.6.5 Hengrui Recent Developments
9.7 CTTQ
9.7.1 CTTQ Castration-resistant Prostate Cancer Drugs Basic Information
9.7.2 CTTQ Castration-resistant Prostate Cancer Drugs Product Overview
9.7.3 CTTQ Castration-resistant Prostate Cancer Drugs Product Market Performance
9.7.4 CTTQ Business Overview
9.7.5 CTTQ Recent Developments
9.8 Sanofi
9.8.1 Sanofi Castration-resistant Prostate Cancer Drugs Basic Information
9.8.2 Sanofi Castration-resistant Prostate Cancer Drugs Product Overview
9.8.3 Sanofi Castration-resistant Prostate Cancer Drugs Product Market Performance
9.8.4 Sanofi Business Overview
9.8.5 Sanofi Recent Developments
9.9 Hansoh
9.9.1 Hansoh Castration-resistant Prostate Cancer Drugs Basic Information
9.9.2 Hansoh Castration-resistant Prostate Cancer Drugs Product Overview
9.9.3 Hansoh Castration-resistant Prostate Cancer Drugs Product Market Performance
9.9.4 Hansoh Business Overview
9.9.5 Hansoh Recent Developments
9.10 Clovis Oncology
9.10.1 Clovis Oncology Castration-resistant Prostate Cancer Drugs Basic Information
9.10.2 Clovis Oncology Castration-resistant Prostate Cancer Drugs Product Overview
9.10.3 Clovis Oncology Castration-resistant Prostate Cancer Drugs Product Market Performance
9.10.4 Clovis Oncology Business Overview
9.10.5 Clovis Oncology Recent Developments
9.11 Zhendong Pharmaceutical
9.11.1 Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Basic Information
9.11.2 Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Product Overview
9.11.3 Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Product Market Performance
9.11.4 Zhendong Pharmaceutical Business Overview
9.11.5 Zhendong Pharmaceutical Recent Developments
9.12 Merck
9.12.1 Merck Castration-resistant Prostate Cancer Drugs Basic Information
9.12.2 Merck Castration-resistant Prostate Cancer Drugs Product Overview
9.12.3 Merck Castration-resistant Prostate Cancer Drugs Product Market Performance
9.12.4 Merck Business Overview
9.12.5 Merck Recent Developments
10 CASTRATION-RESISTANT PROSTATE CANCER DRUGS MARKET FORECAST BY REGION
10.1 Global Castration-resistant Prostate Cancer Drugs Market Size Forecast
10.2 Global Castration-resistant Prostate Cancer Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Castration-resistant Prostate Cancer Drugs Market Size Forecast by Region
10.2.4 South America Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Castration-resistant Prostate Cancer Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Castration-resistant Prostate Cancer Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Castration-resistant Prostate Cancer Drugs by Type (2025-2030)
11.1.2 Global Castration-resistant Prostate Cancer Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Castration-resistant Prostate Cancer Drugs by Type (2025-2030)
11.2 Global Castration-resistant Prostate Cancer Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Castration-resistant Prostate Cancer Drugs Sales (K Units) Forecast by Application
11.2.2 Global Castration-resistant Prostate Cancer Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Castration-resistant Prostate Cancer Drugs Market Size Comparison by Region (M USD)
Table 5. Global Castration-resistant Prostate Cancer Drugs Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Castration-resistant Prostate Cancer Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Castration-resistant Prostate Cancer Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration-resistant Prostate Cancer Drugs as of 2022)
Table 10. Global Market Castration-resistant Prostate Cancer Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Castration-resistant Prostate Cancer Drugs Sales Sites and Area Served
Table 12. Manufacturers Castration-resistant Prostate Cancer Drugs Product Type
Table 13. Global Castration-resistant Prostate Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Castration-resistant Prostate Cancer Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Castration-resistant Prostate Cancer Drugs Market Challenges
Table 22. Global Castration-resistant Prostate Cancer Drugs Sales by Type (K Units)
Table 23. Global Castration-resistant Prostate Cancer Drugs Market Size by Type (M USD)
Table 24. Global Castration-resistant Prostate Cancer Drugs Sales (K Units) by Type (2019-2024)
Table 25. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Castration-resistant Prostate Cancer Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Castration-resistant Prostate Cancer Drugs Market Size Share by Type (2019-2024)
Table 28. Global Castration-resistant Prostate Cancer Drugs Price (USD/Unit) by Type (2019-2024)
Table 29. Global Castration-resistant Prostate Cancer Drugs Sales (K Units) by Application
Table 30. Global Castration-resistant Prostate Cancer Drugs Market Size by Application
Table 31. Global Castration-resistant Prostate Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 32. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Castration-resistant Prostate Cancer Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Castration-resistant Prostate Cancer Drugs Market Share by Application (2019-2024)
Table 35. Global Castration-resistant Prostate Cancer Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Castration-resistant Prostate Cancer Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Castration-resistant Prostate Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 39. Europe Castration-resistant Prostate Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Castration-resistant Prostate Cancer Drugs Sales by Region (2019-2024) & (K Units)
Table 41. South America Castration-resistant Prostate Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Castration-resistant Prostate Cancer Drugs Sales by Region (2019-2024) & (K Units)
Table 43. Pfizer Castration-resistant Prostate Cancer Drugs Basic Information
Table 44. Pfizer Castration-resistant Prostate Cancer Drugs Product Overview
Table 45. Pfizer Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Castration-resistant Prostate Cancer Drugs SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Astellas Castration-resistant Prostate Cancer Drugs Basic Information
Table 50. Astellas Castration-resistant Prostate Cancer Drugs Product Overview
Table 51. Astellas Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Astellas Business Overview
Table 53. Astellas Castration-resistant Prostate Cancer Drugs SWOT Analysis
Table 54. Astellas Recent Developments
Table 55. Janssen Castration-resistant Prostate Cancer Drugs Basic Information
Table 56. Janssen Castration-resistant Prostate Cancer Drugs Product Overview
Table 57. Janssen Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Janssen Castration-resistant Prostate Cancer Drugs SWOT Analysis
Table 59. Janssen Business Overview
Table 60. Janssen Recent Developments
Table 61. AstraZeneca Castration-resistant Prostate Cancer Drugs Basic Information
Table 62. AstraZeneca Castration-resistant Prostate Cancer Drugs Product Overview
Table 63. AstraZeneca Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Recent Developments
Table 66. Bayer Castration-resistant Prostate Cancer Drugs Basic Information
Table 67. Bayer Castration-resistant Prostate Cancer Drugs Product Overview
Table 68. Bayer Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bayer Business Overview
Table 70. Bayer Recent Developments
Table 71. Hengrui Castration-resistant Prostate Cancer Drugs Basic Information
Table 72. Hengrui Castration-resistant Prostate Cancer Drugs Product Overview
Table 73. Hengrui Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Hengrui Business Overview
Table 75. Hengrui Recent Developments
Table 76. CTTQ Castration-resistant Prostate Cancer Drugs Basic Information
Table 77. CTTQ Castration-resistant Prostate Cancer Drugs Product Overview
Table 78. CTTQ Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. CTTQ Business Overview
Table 80. CTTQ Recent Developments
Table 81. Sanofi Castration-resistant Prostate Cancer Drugs Basic Information
Table 82. Sanofi Castration-resistant Prostate Cancer Drugs Product Overview
Table 83. Sanofi Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sanofi Business Overview
Table 85. Sanofi Recent Developments
Table 86. Hansoh Castration-resistant Prostate Cancer Drugs Basic Information
Table 87. Hansoh Castration-resistant Prostate Cancer Drugs Product Overview
Table 88. Hansoh Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Hansoh Business Overview
Table 90. Hansoh Recent Developments
Table 91. Clovis Oncology Castration-resistant Prostate Cancer Drugs Basic Information
Table 92. Clovis Oncology Castration-resistant Prostate Cancer Drugs Product Overview
Table 93. Clovis Oncology Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Clovis Oncology Business Overview
Table 95. Clovis Oncology Recent Developments
Table 96. Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Basic Information
Table 97. Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Product Overview
Table 98. Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Zhendong Pharmaceutical Business Overview
Table 100. Zhendong Pharmaceutical Recent Developments
Table 101. Merck Castration-resistant Prostate Cancer Drugs Basic Information
Table 102. Merck Castration-resistant Prostate Cancer Drugs Product Overview
Table 103. Merck Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Merck Business Overview
Table 105. Merck Recent Developments
Table 106. Global Castration-resistant Prostate Cancer Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Castration-resistant Prostate Cancer Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Castration-resistant Prostate Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Castration-resistant Prostate Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Castration-resistant Prostate Cancer Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Castration-resistant Prostate Cancer Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Castration-resistant Prostate Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Castration-resistant Prostate Cancer Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Castration-resistant Prostate Cancer Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Castration-resistant Prostate Cancer Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Castration-resistant Prostate Cancer Drugs Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Castration-resistant Prostate Cancer Drugs Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Castration-resistant Prostate Cancer Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Castration-resistant Prostate Cancer Drugs Market Size Comparison by Region (M USD)
Table 5. Global Castration-resistant Prostate Cancer Drugs Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Castration-resistant Prostate Cancer Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Castration-resistant Prostate Cancer Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration-resistant Prostate Cancer Drugs as of 2022)
Table 10. Global Market Castration-resistant Prostate Cancer Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Castration-resistant Prostate Cancer Drugs Sales Sites and Area Served
Table 12. Manufacturers Castration-resistant Prostate Cancer Drugs Product Type
Table 13. Global Castration-resistant Prostate Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Castration-resistant Prostate Cancer Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Castration-resistant Prostate Cancer Drugs Market Challenges
Table 22. Global Castration-resistant Prostate Cancer Drugs Sales by Type (K Units)
Table 23. Global Castration-resistant Prostate Cancer Drugs Market Size by Type (M USD)
Table 24. Global Castration-resistant Prostate Cancer Drugs Sales (K Units) by Type (2019-2024)
Table 25. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Castration-resistant Prostate Cancer Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Castration-resistant Prostate Cancer Drugs Market Size Share by Type (2019-2024)
Table 28. Global Castration-resistant Prostate Cancer Drugs Price (USD/Unit) by Type (2019-2024)
Table 29. Global Castration-resistant Prostate Cancer Drugs Sales (K Units) by Application
Table 30. Global Castration-resistant Prostate Cancer Drugs Market Size by Application
Table 31. Global Castration-resistant Prostate Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 32. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Castration-resistant Prostate Cancer Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Castration-resistant Prostate Cancer Drugs Market Share by Application (2019-2024)
Table 35. Global Castration-resistant Prostate Cancer Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Castration-resistant Prostate Cancer Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Castration-resistant Prostate Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 39. Europe Castration-resistant Prostate Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Castration-resistant Prostate Cancer Drugs Sales by Region (2019-2024) & (K Units)
Table 41. South America Castration-resistant Prostate Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Castration-resistant Prostate Cancer Drugs Sales by Region (2019-2024) & (K Units)
Table 43. Pfizer Castration-resistant Prostate Cancer Drugs Basic Information
Table 44. Pfizer Castration-resistant Prostate Cancer Drugs Product Overview
Table 45. Pfizer Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Castration-resistant Prostate Cancer Drugs SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Astellas Castration-resistant Prostate Cancer Drugs Basic Information
Table 50. Astellas Castration-resistant Prostate Cancer Drugs Product Overview
Table 51. Astellas Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Astellas Business Overview
Table 53. Astellas Castration-resistant Prostate Cancer Drugs SWOT Analysis
Table 54. Astellas Recent Developments
Table 55. Janssen Castration-resistant Prostate Cancer Drugs Basic Information
Table 56. Janssen Castration-resistant Prostate Cancer Drugs Product Overview
Table 57. Janssen Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Janssen Castration-resistant Prostate Cancer Drugs SWOT Analysis
Table 59. Janssen Business Overview
Table 60. Janssen Recent Developments
Table 61. AstraZeneca Castration-resistant Prostate Cancer Drugs Basic Information
Table 62. AstraZeneca Castration-resistant Prostate Cancer Drugs Product Overview
Table 63. AstraZeneca Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Recent Developments
Table 66. Bayer Castration-resistant Prostate Cancer Drugs Basic Information
Table 67. Bayer Castration-resistant Prostate Cancer Drugs Product Overview
Table 68. Bayer Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bayer Business Overview
Table 70. Bayer Recent Developments
Table 71. Hengrui Castration-resistant Prostate Cancer Drugs Basic Information
Table 72. Hengrui Castration-resistant Prostate Cancer Drugs Product Overview
Table 73. Hengrui Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Hengrui Business Overview
Table 75. Hengrui Recent Developments
Table 76. CTTQ Castration-resistant Prostate Cancer Drugs Basic Information
Table 77. CTTQ Castration-resistant Prostate Cancer Drugs Product Overview
Table 78. CTTQ Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. CTTQ Business Overview
Table 80. CTTQ Recent Developments
Table 81. Sanofi Castration-resistant Prostate Cancer Drugs Basic Information
Table 82. Sanofi Castration-resistant Prostate Cancer Drugs Product Overview
Table 83. Sanofi Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sanofi Business Overview
Table 85. Sanofi Recent Developments
Table 86. Hansoh Castration-resistant Prostate Cancer Drugs Basic Information
Table 87. Hansoh Castration-resistant Prostate Cancer Drugs Product Overview
Table 88. Hansoh Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Hansoh Business Overview
Table 90. Hansoh Recent Developments
Table 91. Clovis Oncology Castration-resistant Prostate Cancer Drugs Basic Information
Table 92. Clovis Oncology Castration-resistant Prostate Cancer Drugs Product Overview
Table 93. Clovis Oncology Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Clovis Oncology Business Overview
Table 95. Clovis Oncology Recent Developments
Table 96. Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Basic Information
Table 97. Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Product Overview
Table 98. Zhendong Pharmaceutical Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Zhendong Pharmaceutical Business Overview
Table 100. Zhendong Pharmaceutical Recent Developments
Table 101. Merck Castration-resistant Prostate Cancer Drugs Basic Information
Table 102. Merck Castration-resistant Prostate Cancer Drugs Product Overview
Table 103. Merck Castration-resistant Prostate Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Merck Business Overview
Table 105. Merck Recent Developments
Table 106. Global Castration-resistant Prostate Cancer Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Castration-resistant Prostate Cancer Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Castration-resistant Prostate Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Castration-resistant Prostate Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Castration-resistant Prostate Cancer Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Castration-resistant Prostate Cancer Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Castration-resistant Prostate Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Castration-resistant Prostate Cancer Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Castration-resistant Prostate Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Castration-resistant Prostate Cancer Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Castration-resistant Prostate Cancer Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Castration-resistant Prostate Cancer Drugs Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Castration-resistant Prostate Cancer Drugs Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Castration-resistant Prostate Cancer Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Castration-resistant Prostate Cancer Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Castration-resistant Prostate Cancer Drugs Market Size (M USD), 2019-2030
Figure 5. Global Castration-resistant Prostate Cancer Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Castration-resistant Prostate Cancer Drugs Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Castration-resistant Prostate Cancer Drugs Market Size by Country (M USD)
Figure 11. Castration-resistant Prostate Cancer Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Castration-resistant Prostate Cancer Drugs Revenue Share by Manufacturers in 2023
Figure 13. Castration-resistant Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Castration-resistant Prostate Cancer Drugs Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Castration-resistant Prostate Cancer Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Castration-resistant Prostate Cancer Drugs Market Share by Type
Figure 18. Sales Market Share of Castration-resistant Prostate Cancer Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Castration-resistant Prostate Cancer Drugs by Type in 2023
Figure 20. Market Size Share of Castration-resistant Prostate Cancer Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Castration-resistant Prostate Cancer Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Castration-resistant Prostate Cancer Drugs Market Share by Application
Figure 24. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Application in 2023
Figure 26. Global Castration-resistant Prostate Cancer Drugs Market Share by Application (2019-2024)
Figure 27. Global Castration-resistant Prostate Cancer Drugs Market Share by Application in 2023
Figure 28. Global Castration-resistant Prostate Cancer Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Castration-resistant Prostate Cancer Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Castration-resistant Prostate Cancer Drugs Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Castration-resistant Prostate Cancer Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Castration-resistant Prostate Cancer Drugs Sales Market Share by Country in 2023
Figure 37. Germany Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Castration-resistant Prostate Cancer Drugs Sales Market Share by Region in 2023
Figure 44. China Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (K Units)
Figure 50. South America Castration-resistant Prostate Cancer Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Castration-resistant Prostate Cancer Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Castration-resistant Prostate Cancer Drugs Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Castration-resistant Prostate Cancer Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Castration-resistant Prostate Cancer Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Castration-resistant Prostate Cancer Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Castration-resistant Prostate Cancer Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Castration-resistant Prostate Cancer Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Castration-resistant Prostate Cancer Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Castration-resistant Prostate Cancer Drugs Market Size (M USD), 2019-2030
Figure 5. Global Castration-resistant Prostate Cancer Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Castration-resistant Prostate Cancer Drugs Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Castration-resistant Prostate Cancer Drugs Market Size by Country (M USD)
Figure 11. Castration-resistant Prostate Cancer Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Castration-resistant Prostate Cancer Drugs Revenue Share by Manufacturers in 2023
Figure 13. Castration-resistant Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Castration-resistant Prostate Cancer Drugs Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Castration-resistant Prostate Cancer Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Castration-resistant Prostate Cancer Drugs Market Share by Type
Figure 18. Sales Market Share of Castration-resistant Prostate Cancer Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Castration-resistant Prostate Cancer Drugs by Type in 2023
Figure 20. Market Size Share of Castration-resistant Prostate Cancer Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Castration-resistant Prostate Cancer Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Castration-resistant Prostate Cancer Drugs Market Share by Application
Figure 24. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Application in 2023
Figure 26. Global Castration-resistant Prostate Cancer Drugs Market Share by Application (2019-2024)
Figure 27. Global Castration-resistant Prostate Cancer Drugs Market Share by Application in 2023
Figure 28. Global Castration-resistant Prostate Cancer Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Castration-resistant Prostate Cancer Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Castration-resistant Prostate Cancer Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Castration-resistant Prostate Cancer Drugs Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Castration-resistant Prostate Cancer Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Castration-resistant Prostate Cancer Drugs Sales Market Share by Country in 2023
Figure 37. Germany Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Castration-resistant Prostate Cancer Drugs Sales Market Share by Region in 2023
Figure 44. China Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (K Units)
Figure 50. South America Castration-resistant Prostate Cancer Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Castration-resistant Prostate Cancer Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Castration-resistant Prostate Cancer Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Castration-resistant Prostate Cancer Drugs Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Castration-resistant Prostate Cancer Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Castration-resistant Prostate Cancer Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Castration-resistant Prostate Cancer Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Castration-resistant Prostate Cancer Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Castration-resistant Prostate Cancer Drugs Market Share Forecast by Application (2025-2030)
